Clik here to view.
MassDevice.com +3 | The top 3 med-tech stories for May 23, 2013
If you read nothing else today, make sure you're still in the know with MassDevice +3.Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of...
View ArticleClik here to view.
FDA green-lights 1st HbA1cDx diabetes test | MassDevice.com On Call
U.S. healthcare regulators clear Roche's COBAS INTEGRA 800 Tina-quant HbA1cDx assay, the 1st HbA1c test approved for diagnosing diabetes.MASSDEVICE ON CALL — The FDA this week officially approved Swiss...
View ArticleClik here to view.
J&J sues Shasta Technologies for logo infringement
J&J subsidiary Lifescan asks the courts to ban Shasta from using its logo, saying problems with Shasta's products are harming the Lifescan brand. Johnson & Johnson (NYSE:JNJ) subsidiary...
View ArticleClik here to view.
When regulators are ignored
FDA's official blog brought to you from FDA's senior leadership and staff stationed at home and abroad - sharing news, background, announcements and other information about the work done at the FDA on...
View ArticleClik here to view.
Medical device tax: Theragenics, layoffs and the essence of the fight for repeal
Theragenics' recent rhetoric about the medical device tax captures many of the repeal movement's high points: layoffs, restructuring and the myth of a medtech windfall contained in healthcare...
View ArticleClik here to view.
Sunshine Heart seeks $25.5M in equity funding round | Wall Street Beat
Sunshine Heart raises $1.5 million of a hoped-for $25.5 million equity funding round.Eden Prairie, Minn., and Sydney-based medical device company Sunshine Heart (ASX:SHC) is looking to raise funds in a...
View ArticleClik here to view.
Johnson and Johnson executive splits for the corner office at Itamar Medical...
J&J's former head of global cardiology makes the jump to CEO at Itamar Medical Former J&J executive joins Itamar Medical as CEONews Well, Personnel, Personnel Movesread more
View ArticleClik here to view.
Uroplasty touts positive 3-year outcomes for neurostimulation in treatment of...
Covidien’s 3-year study results showing positive outcomes for its Urgent PC Neuromodulation system in treatment of overactive bladder are slated to appear in an upcoming issue of the Journal of...
View ArticleClik here to view.
FDA clears 21-inch medical monitors from NEC Display Solutions
NEC Display Solutions wins 510(k) clearance for its 21-inch medical monitor systems.NEC Display Solutions got the go-ahead from the FDA to begin selling its 21-inch medical monitor, the company...
View ArticleClik here to view.
FzioMed's post-surgical gel lands a regulatory win in Australia
Aussie regulators give the green light to FizioMed's Dynavisc, an absorbable gel applied to tendons and nerves after surgery.Privately held medical device maker FzioMed won Australian regulatory...
View ArticleClik here to view.
Legal: Intuitive Surgical wins jury trial in da Vinci training claim
Jurors in Washington state vote 10-2 for Intuitive Surgical in the first of many lawsuits over the company's da Vinci robotic surgical systemIntuitive Surgical (NSDQ:ISRG) won a legal victory in a...
View ArticleClik here to view.
EuroPCR: St. Jude's EnligHTN device shows promising 1-year trial results
St. Jude presents 1-year data supporting its EnligHTN device for patients with drug-resistant high blood pressureSt. Jude Medical (NYSE:STJ) released results for its EnligHTN renal denervation system...
View ArticleClik here to view.
EuroPCR: Volcano, Boston Scientific team up for accurate stent placement study
Volcano and Boston Scientific use their respective devices simultaneously for more accurate stent placement in a new study announced at EuroPCRVolcano Corporation (NSDQ:VOLC) and Boston Scientific...
View ArticleClik here to view.
EuroPCR: Medtronic moving forward with its renal denervation study
Medtronic finishes enrolling patients in a U.S. trial of its Simplicity renal denervation system to treat high blood pressureMedtronic (NYSE:MDT) has wrapped up patient enrollment in its Symplicity...
View ArticleClik here to view.
The FDA: Now more popular than the IRS, Federal Reserve and Dept. of Homeland...
A new Gallup poll shows that American's opinion of the FDA is on the upswingAmerican's view of the FDA are improving, according to a recent Gallup survey of opinions on federal agencies. The federal...
View ArticleClik here to view.
MassDevice.com +7 | The top 7 med-tech stories for the week of May 20, 2013
If you read nothing else this weekend, make sure you're still in the know with MassDevice +7.Say hello to MassDevice +7, a bite-sized view of the top seven med-tech stories of the week. This latest...
View ArticleClik here to view.
Is Valeant About To Make A Bold Bid For Bausch & Lomb?
MassDevice columnist Stephen Simpson on rumors that Valeant may be prepping a $9 billion bid for Bausch+LombBy Stephen SimpsonNever let it be said that Valeant (NYSE: VRX) management is shy about doing...
View ArticleClik here to view.
pSivida wins approval for Iluvien in Germany
German healthcare regulators approve pSivida’s Iluvien drug-device combination product for treatment of diabetic macular edema.pSivida's (NSDQ:PSDV) announced that it won German approval for its...
View ArticleClik here to view.
MassDevice.com +3 | The top 3 med-tech stories for May 27, 2013
If you read nothing else today, make sure you're still in the know with MassDevice +3.Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of...
View ArticleClik here to view.
Pediatric ICD study finds higher rate of failure for Sprint Fidelis leads in...
Recalled medical devices, such as Medtronic's Sprint Fidelis defibrillator leads, may pose a high and perhaps under-recognized risk in pediatric populations.MASSDEVICE ON CALL — When Medtronic...
View Article
